This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Lithium

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Lithium has been used as a medicine for over a century, originally in the treatment of gout, and in the early 1940's lithium was used for cardiac patients as a salt in a sodium chloride free diet. However because of side effects its use for these patients was abandoned.

Lithium is used as a psychiatric treatment against the recurrence of mania and as a treatment, and prophylaxis for, depressive disorders. Lithium may have some antidepressant effects but these are less than those of less-toxic agents such as tricyclics. Lithium has also been claimed to be of use in reduction of premenstrual tension.

Lithium-enhanced use of high dose tricyclics is a treatment alternative for depressive illness where the use of high dose tricyclics alone has failed to have a therapeutic effect (see notes).

The summary of product characteristics should be consulted before prescribing this drug.

Notes:

  • dosulepin, phenelzine, combined antidepressants, and lithium augmentation of antidepressants should only be routinely initiated by specialist mental health professionals, including General Practitioners with a Special Interest in Mental Health (1)

Reference:

  1. NICE (December 2004).Depression Management of depression in primary and secondary care

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.